Page last updated: 2024-11-04

sulfamethoxypyridazine and Pseudotumor Cerebri

sulfamethoxypyridazine has been researched along with Pseudotumor Cerebri in 1 studies

Sulfamethoxypyridazine: A sulfanilamide antibacterial agent.
sulfamethoxypyridazine : A sulfonamide consisting of pyridazine having a methoxy substituent at the 6-position and a 4-aminobenzenesulfonamido group at the 3-position.

Pseudotumor Cerebri: A condition marked by raised intracranial pressure and characterized clinically by HEADACHES; NAUSEA; PAPILLEDEMA, peripheral constriction of the visual fields, transient visual obscurations, and pulsatile TINNITUS. OBESITY is frequently associated with this condition, which primarily affects women between 20 and 44 years of age. Chronic PAPILLEDEMA may lead to optic nerve injury (see OPTIC NERVE DISEASES) and visual loss (see BLINDNESS).

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Soriani, S1
Voghenzi, A1
Scorrano, M1

Other Studies

1 other study available for sulfamethoxypyridazine and Pseudotumor Cerebri

ArticleYear
[Fontanelle bombée : the possible consequence of sulphenazone therapy].
    Minerva pediatrica, 1981, May-31, Volume: 33, Issue:10

    Topics: Antipyrine; Female; Fever; Humans; Infant; Pseudotumor Cerebri; Sulfamethoxypyridazine

1981